Entero Therapeutics Inc (ENTO)
0.4533
+0.04
(+9.23%)
USD |
NASDAQ |
Nov 22, 16:00
0.4433
-0.01
(-2.21%)
After-Hours: 20:00
Entero Therapeutics Total Liabilities (Quarterly): 15.77M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.77M |
| June 30, 2024 | 15.49M |
| March 31, 2024 | 13.27M |
| December 31, 2023 | 3.280M |
| September 30, 2023 | 2.648M |
| June 30, 2023 | 3.446M |
| March 31, 2023 | 2.821M |
| December 31, 2022 | 2.698M |
| September 30, 2022 | 6.926M |
| June 30, 2022 | 18.12M |
| March 31, 2022 | 18.07M |
| December 31, 2021 | 19.61M |
| September 30, 2021 | 19.39M |
| June 30, 2021 | 6.740M |
| March 31, 2021 | 3.581M |
| December 31, 2020 | 15.56M |
| September 30, 2020 | 2.657M |
| June 30, 2020 | 7.659M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.143M |
| December 31, 2019 | 4.286M |
| September 30, 2019 | 6.234M |
| June 30, 2019 | 6.664M |
| March 31, 2019 | 6.243M |
| December 31, 2018 | 2.996M |
| September 30, 2018 | 3.046M |
| June 30, 2018 | 4.111M |
| March 31, 2018 | 4.149M |
| December 31, 2017 | 3.819M |
| September 30, 2017 | 4.041M |
| June 30, 2017 | 4.120M |
| March 31, 2017 | 3.953M |
| December 31, 2016 | 3.541M |
| September 30, 2016 | 17.95M |
| June 30, 2016 | 15.81M |
| March 31, 2016 | 11.73M |
| December 31, 2015 | 10.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.648M
Minimum
Sep 2023
19.61M
Maximum
Dec 2021
9.358M
Average
6.833M
Median
Total Liabilities (Quarterly) Benchmarks
| Pulmatrix Inc | 0.59M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.82M |
| Shareholders Equity (Quarterly) | 70.05M |